Akero Therapeutics, Inc.

AKRO:NasdaqGS

7.407%
(Fri, 01 Jul 2022 20:00:04 +0000)
Nasdaq Real Time Price

Realtime signal
SELL
BUY
Long Term Signal SELL
Pivot R2 9.88
Pivot R1 9.67
Last 10.15
Pivot S1 9.25
Pivot S2 9.04
 Akero Therapeutics, Inc.
Week52high 26.98
Week52low 7.52
Day50MovingAvg 9.6244
Day200MovingAvg 17.10195
Beta (5Y Monthly) 0.78
PE Ratio (TTM) 0.00
EPS (TTM) -3.202
Earnings Date Aug 11 - Aug 15
Recommendation Trend
Jul Jun May Apr
Strong Buy 0 2 2 0
Buy 0 3 3 0
Hold 0 1 1 0
Sell 0 0 0 0
Strong Sell 0 0 0 0
Total 0 6 6 0
Upgrade Downgrade History
Morgan Stanley
Nov 15
Maintains
to Equal-Weight
HC Wainwright & Co.
Nov 15
Maintains
to Buy
Morgan Stanley
Oct 19
Downgrade
Overweight to Equal-Weight
B of A Securities
Sep 10
Initiated
to Buy
HC Wainwright & Co.
Aug 16
Maintains
to Buy
Morgan Stanley
Mar 23
Maintains
to Overweight
HC Wainwright & Co.
Mar 23
Maintains
to Buy
Canaccord Genuity
Mar 18
Maintains
to Buy
Chardan Capital
Mar 17
Maintains
to Buy
HC Wainwright & Co.
Mar 17
Maintains
to Buy